Sign in
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors (vol 38, pg 160, 2020)
Journal article   Open access  Peer reviewed

Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors (vol 38, pg 160, 2020)

Sadal Refae, Jocelyn Gal, Nathalie Ebran, Josiane Otto, Delphine Borchiellini, Frederic Peyrade, Emmanuel Chamorey, Patrick Brest, Gerard Milano and Esma Saada-Bouzid
Investigational new drugs, Vol.39(1), pp.287-292
01/02/2021
PMID: 32500464

Abstract

Life Sciences & Biomedicine Oncology Pharmacology & Pharmacy Science & Technology
Corrections are needed to the original version of this article.
url
https://doi.org/10.1007/s10637-020-00954-xView
Published (Version of record) Open

Metrics

1 Record Views

Details